Alinity m SARS-CoV-2 assays run on the Alinity m system which offer workflow efficiency and the high throughput solution for testing specimens from symptomatic and asymptomatic patients the laboratory requires today. Together with broad sample type claims including pooling, laboratories are empowered to meet their public health needs to diagnose or screen for COVID-19.
- Simple and clear result reporting to aid clinicians with patient management.
- Dual target design within highly conserved target regions of the virus ensures detection of current strain and safeguards against viral evolution
- Simple workflow with primary sample tube loading and true random access powered by ReadiFlex Technology provide operational efficiencies to address fluctuating testing demands with the existing lab staff.
The Alinity m SARS-CoV-2 AMP Kit is manufactured and approved for use by the Therapeutic Goods Administration (TGA) .
Buy the Alinity m SARS-CoV-2 AMP Kit for Your WorkPlace
If your company or organisation is interested in rapid testing solutions, contact us today for help procuring the Alinity m SARS-CoV-2 AMP Kit for detecting SARS-CoV-2 or other rapid tests authorised by the Therapeutic Goods Administration (TGA) .
If you’re interested in rapid testing solutions, contact us today for a quote. You can also place an order for the Alinity m SARS-CoV-2 AMP Kit or other rapid tests approved by the TGA.
Our team at Rapid Tests Australia can also assist with implementing a rapid testing program to protect your workplace from the risks of COVID-19.